Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
lampsia
- Development stage
- Preclinical
- Lead developer
- Comanche Biopharma
- Administration
- Oral
01
Overview
Lampsia is identified as a component within a Traditional Chinese Medicine (TCM) mixture, specifically referred to as "Remove blood stasis and settle lampsia mixture" (祛瘀定痫合剂). This mixture is being investigated for the prevention and treatment of epilepsy complicated with cognitive impairment. Within the context of TCM, "settle lampsia" (定痫, dìng xián) refers to the action of calming convulsions or settling epilepsy. Therefore, lampsia is understood as an active principle or ingredient contributing to the anti-epileptic effects of the TCM formulation. It is not a standalone Western pharmaceutical drug but rather a concept or component within a traditional herbal remedy.
Beyond the preview
Go deeper on lampsia.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on lampsia.